Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its own version of Novo Nordisk’s Wegovy oral weight-loss drug.
stock
-
-
Hims & Hers also said it’s selling a cancer-detection test that’s featured in its Super Bowl ad, which plays like a commentary on the wealthy’s access to better healthcare.
-
Novo Nordisk shares rallied on Friday in what’s still been a painful week as the Food and Drug Administration may weigh in on the side of the Danish drugmaker in…
-
Super Micro’s revenue exploded to $12.7 billion as delayed orders finally materialized, but aggressive competition and rising costs pushed gross margins to a razor-thin 6.3%
-
Stocks
U.S. stock futures fall after bitcoin’s weekend drop, as gold and silver’s sell-off may be bleeding into other markets
U.S. stock futures fell Sunday, after a weekend slide by bitcoin and Friday’s massive sell-off in precious metals capped a tumultuous first month of 2026.
-
U.S. stock futures slumped and gold hit a record high Sunday as investors look ahead to a Fed interest-rate decision and Big Tech earnings this week.
-
If December’s lows are broken during the first quarter of a new year, a bear market often follows.
-
Stocks
Trump, Greenland and the mounting fear of war: How the stock market reacts to big geopolitical events.
HSBC thinks the U.S. is close to the ‘danger zone’ but sees support from the Fed and from fourth-quarter earnings, suggesting the market is already technically oversold.
-
Stocks
These charts show the stock market giving investors a lot to like — for now — as the S&P 500 nears 7,000
More stocks are making new 52-week highs and volatility is low.
-
Zhanna Hapanovich/iStock via Getty Images Penumbra (PEN) rose 3.8% at least partly amid some takeover speculation. Penumbra (PEN) may have drawn takeover interest, according to traders, who cited a Betaville…
